Capella BioScience

Capella BioScience

Capella BioScience

Capella Bioscience Limited engages in the discovery and development of monoclonal antibodies
Founded
2014
Raised
$15.5M
Follow us
Alexa global traffic share
Latest funding
£11,000,000
Venture capital (Series A) - 2016
Osage University Partners Advent Life Sciences Medicxi Ventures
Team Size
1–10
Employees
£11,000,000 Venture capital (Series A)
FinSMEs

Capella Bioscience Closes £11M Series A Financing

Funding Health